Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,587Revenue $M1,212Net Margin (%)-36.7Z-Score7.2
Enterprise Value $M14,629EPS $-2.0Operating Margin %-74.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-80.5Higher ROA y-yN
Price/Book11.410-y EBITDA Growth Rate %0Quick Ratio2.4Cash flow > EarningsY
Price/Sales12.25-y EBITDA Growth Rate %0Current Ratio2.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-2,121.1ROA % (ttm)-19.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-32.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M233ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 66.92-4%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 66.92-16%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 66.92-9%Add 140.58%5,990,000
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 66.9245%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 66.9245%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 66.9225%Add 40%700,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 66.9225%Sold Out0
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 66.9225%Reduce -25%150,000
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 66.9225%Sold Out0
VRTXDaniel Loeb 2012-06-30 Buy 0.85%$35.75 - $65.62
($50.92)
$ 66.9231%New holding, 500000 sh.500,000
VRTXJohn Burbank 2012-06-30 Buy 0.38%$35.75 - $65.62
($50.92)
$ 66.9231%New holding, 200000 sh.200,000
VRTXJoel Greenblatt 2012-06-30 Buy 0.08%$35.75 - $65.62
($50.92)
$ 66.9231%New holding, 20025 sh.20,025
VRTXJohn Hussman 2012-06-30 Sold Out -0.93%$35.75 - $65.62
($50.92)
$ 66.9231%Sold Out0
VRTXGeorge Soros 2012-06-30 Reduce-0.05%$35.75 - $65.62
($50.92)
$ 66.9231%Reduce -44%112,000
VRTXJean-Marie Eveillard 2012-06-30 Sold Out -0.02%$35.75 - $65.62
($50.92)
$ 66.9231%Sold Out0
VRTXGeorge Soros 2012-03-31 Buy 0.12%$32.2 - $42.94
($35.95)
$ 66.9286%New holding, 200000 sh.200,000
VRTXJean-Marie Eveillard 2012-03-31 Buy 0.02%$32.2 - $42.94
($35.95)
$ 66.9286%New holding, 110000 sh.110,000
VRTXJohn Hussman 2012-03-31 Reduce-0.34%$32.2 - $42.94
($35.95)
$ 66.9286%Reduce -35%1,170,000
VRTXRay Dalio 2012-03-31 Sold Out -0.24%$32.2 - $42.94
($35.95)
$ 66.9286%Sold Out0
VRTXJohn Hussman 2011-12-31 Buy 0.96%$26.6 - $45.12
($35.09)
$ 66.9291%New holding, 1800000 sh.1,800,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX Vanguard Health Care Fund 2013-12-3110,981,5004.722.5+54.06%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUELLER PETEREVP, Global R&D, CSO 2014-04-15Sell7,500$61.6310.82view
ULLIAN ELAINEDirector 2014-04-09Sell2,500$70-2.43view
SACHS BRUCE IDirector 2014-03-21Sell8,700$74.59-8.43view
MUELLER PETEREVP, Global R&D, CSO 2014-03-17Sell7,500$78.29-12.76view
SACHS BRUCE IDirector 2014-02-20Sell8,300$83.66-18.36view
MUELLER PETEREVP, Global R&D, CSO 2014-02-18Sell7,500$82.59-17.3view
LEIDEN JEFFREY MCEO & President 2014-02-07Sell35,944$80-14.63view
Connolly ThomasSVP, Human Resources 2014-02-05Sell938$77.61-12view
SACHS BRUCE IDirector 2014-01-22Sell8,300$84.47-19.14view
Pace Megan ESVP, Corp. Communications 2014-01-21Sell1,250$85-19.65view

Press Releases about VRTX :

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 
Achillion Will Surge If New Drug Is Successful Apr 21 2012 
Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
4 Pharmaceuticals with Long and Short Opportunities Feb 28 2012 

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide